Pharmaceutical Information |
Drug Name |
Papaverine hydrochloride |
Drug ID |
BADD_D01671 |
Description |
An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. |
Indications and Usage |
For the treatment of impotence and vasospasms. |
Marketing Status |
Not Available |
ATC Code |
A03AD01; G04BE02 |
DrugBank ID |
DB01113
|
KEGG ID |
D02218
|
MeSH ID |
D010208
|
PubChem ID |
6084
|
TTD Drug ID |
D0NJ3V
|
NDC Product Code |
76003-0850; 49452-5000; 14789-121; 0517-4002; 72516-024; 54288-142; 0395-8147; 43235-0009; 42981-154; 62991-1203; 38779-0454; 51927-1775; 51927-0223 |
Synonyms |
Papaverine | Pavatym | Pavabid | Cerespan | Papaverine Hydrochloride | Hydrochloride, Papaverine |
|
Chemical Information |
Molecular Formula |
C20H21NO4.ClH |
CAS Registry Number |
61-25-6 |
SMILES |
COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.Cl |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|